The use of sodium‐glucose co‐transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?-Reference-Cited by-同舟云学术

The use of sodium‐glucose co‐transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?

Published:2020-01-06 Issue:5 Volume:45 Page:883-891
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Koufakis Theocharis¹^ORCID,Mustafa Omar G.²,Ajjan Ramzi A.³,Garcia‐Moll Xavier⁴,Zebekakis Pantelis¹^ORCID,Dimitriadis George⁵,Kotsa Kalliopi¹^ORCID

Affiliation:

1. Division of Endocrinology and Metabolism and Diabetes Center First Department of Internal Medicine Medical School AHEPA University Hospital Aristotle University of Thessaloniki Thessaloniki Greece

2. Department of Diabetes King's College Hospital London UK

3. Leeds Institute for Cardiovascular and Metabolic Medicine University of Leeds Ringgold Standard Institution Leeds UK

4. Cardiology Department Hospital de la Santa Creu i Sant Pau Universitat Autònoma Barcelona Spain

5. Second Department of Internal Medicine Research Institute and Diabetes Center, Athens University Medical School ‘Attikon’ University Hospital National and Kapodistrian University of Athens Athens Greece

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13107

Reference69 articles.

1. Cardiovascular outcome trials of the newer anti-diabetic medications

2. Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications

3. Sodium-Glucose Co-Transport Inhibitors

4. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

5. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19;Endocrine;2024-03-06

2. Antidiabéticos Não Insulínicos na Abordagem da Hiperglicemia nos Doentes Hospitalizados por Doença Aguda Não Crítica;Acta Médica Portuguesa;2024-02-05

3. Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study;Diabetes Care;2023-12-05

4. Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia;Endocrine Practice;2023-12

5. Empagliflozin-associated postoperative mixed metabolic acidosis. Case report and review of pathogenesis;BMC Endocrine Disorders;2023-04-14